| Pharmaceutical active ingredients: |
| HydrochlorothiazideLosartan Potassium |
| Available forms, composition and doses of Lorsar + HCT: |
| N / A |
| Lorsar + HCT medical category: |
| Human:Angiotensin II receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03AX01 - Hydrochlorothiazide, combinationsC09DA01 - Losartan and diuretics |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Hexal |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Loortan Plus | Hydrochlorothiazide; Losartan Potassium | Therabel Pharma |
| Loplac-D | Hydrochlorothiazide; Losartan Potassium | Casasco Laboratorios |
| Loril-HT | Hydrochlorothiazide; Losartan Potassium | Essweil Pharma |
| Lorista H | Hydrochlorothiazide; Losartan Potassium | KRKA |
| Lorista HD | Hydrochlorothiazide; Losartan Potassium | KRKA |
| Lortaan Plus | Hydrochlorothiazide; Losartan Potassium | Merck; Medinfar Laboratorio |
| Lorzaar Plus | Hydrochlorothiazide; Losartan Potassium | Merck |
| Lorzan Plus | Hydrochlorothiazide; Losartan Potassium | Clinbaxy International |
| Losacar-H | Hydrochlorothiazide; Losartan Potassium | Zydus Cadila |
| Losacor D | Hydrochlorothiazide; Losartan Potassium | Roemmers Laboratorios |